Search results
Results from the WOW.Com Content Network
Nature Reviews Clinical Oncology is a monthly peer-reviewed academic journal published by Nature Portfolio. The journal was renamed from Nature Clinical Practice Oncology in April 2009. [1] Nature Reviews Clinical Oncology is one of eight Clinical Review journals published by Nature Portfolio. It covers research developments and clinical ...
npj series. The Nature Partner Journals series, abbreviated npj, is a series of online-only, open access, journals.It was launched in April 2014 with three journals: npj Primary Care Respiratory Medicine, npj Biofilms and Microbiomes, and npj Schizophrenia.
Nature Reviews Cancer: Oncology: Nature Publishing Group: English: 2001–present Nature Reviews Cardiology: Cardiology: Nature Publishing Group: English: 2004–present Nature Reviews Clinical Oncology: Oncology: Nature Publishing Group: English: 2004–present Nature Reviews Disease Primers: Medicine: Nature Publishing Group: English: 2015 ...
Due to their stability, the 27 colorectal PDX models may be able to serve as pre-clinical models in future drug studies. Drug resistance studies have been conducted using colorectal PDX models. In one study, researchers found that the models predicted patient responsiveness to cetuximab with 90% accuracy. [ 23 ]
Nature Reviews Cancer; Discipline: Oncology: Language: English: ... Standard abbreviations ... Nature Reviews Cancer is a monthly review journal covering the field of ...
Cancer immunology (immuno-oncology) is an interdisciplinary branch of biology and a sub-discipline of immunology that is concerned with understanding the role of the immune system in the progression and development of cancer; the most well known application is cancer immunotherapy, which utilises the immune system as a treatment for cancer.
An example of this is a sensitive double gradient centrifugation and magnetic cell sorting detection and enumeration method which has been used to detect circulating epithelial cancer cells in breast cancer patients by negative selection. [77]
An example is the gene encoding the enzyme thiopurine methyl-transferase (TPMPT). [34] Individuals with mutations in the TPMT gene are unable to metabolize large amounts of the leukemia drug, mercaptopurine , which potentially causes a fatal drop in white blood count for such patients.